ARK Diagnostics is a leading provider of in vitro diagnostic immunoassays for therapeutic drug monitoring and urine drug testing, offering a wide range of assays for the qualitative and quantitative determination of various substances such as tramadol, voriconazole, EDDP, fentanyl, and methotrexate.
Their next generation assays are known for their exceptional technical performance, liquid stability, and ready-to-use convenience, with applications available for clinical chemistry systems. With a focus on improving healthcare, ARK Diagnostics is committed to developing innovative solutions for clinical laboratory testing, including assays for epilepsy, cancer, antibiotics, antifungal, urine drug testing, antiretroviral, veterinary, and oral anticoagulants.
Generated from the website